- /
- Supported exchanges
- / US
- / VVOS.NASDAQ
Vivos Therapeutics Inc (VVOS NASDAQ) stock market data APIs
Vivos Therapeutics Inc Financial Data Overview
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Vivos Therapeutics Inc data using free add-ons & libraries
Get Vivos Therapeutics Inc Fundamental Data
Vivos Therapeutics Inc Fundamental data includes:
- Net Revenue: 19 568 K
- EBITDA: -21 005 000
- Earnings Per Share: -2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-18
- EPS/Forecast: -0.415
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Vivos Therapeutics Inc News
New
Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity
LITTLETON, Colo., June 22, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on th...
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering
LITTLETON, Colo., June 11, 2026 (GLOBE NEWSWIRE) -- VivosTherapeutics,Inc.(“Vivos”orthe“Company”)(NASDAQ:VVOS), a leading medical device and healthcare services company focused on the treatm...
Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026
LITTLETON, Colo., June 08, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc.(“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on ...
Pre-Market Movers: TNGX, WOK, GOCO Set The Path
(RTTNews) - Biotech companies are seeing significant pre-market activity this Monday, hinting at possible breakout opportunities. Assessing sentiment and momentum in the premarket sets the tone for a...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.